ClinicalTrials.govpublic full text
Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy
non small cell lung cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 160336
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.